Vaginal and Vulvar Cancer 2022
DOI: 10.1136/ijgc-2022-esgo.994
|View full text |Cite
|
Sign up to set email alerts
|

2022-RA-1258-ESGO Patient walk to the operating theatre as a new tool for patient empowerment – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients

Abstract: COVID-19 infections (CI) amongst patients.Results There was no delay in the simulation training. Wet lab training was delayed due to temporary center closure. The surgeon's learning curve was slower at the beginning of the program. This was attributed to the lower influx of patients as a result of prioritization, lesser operative sessions, and delays in the mandatory training completion. 41 RS procedures were done in the first 8 month following a COVID-19 free pathway and were operated in an elective surgery h… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles